Using a neural interface to help people with tetraplegia control devices with their thoughts
Official title: Single Neuron Population Dynamics in Human Speech Motor Cortex for a Speech Prosthesis
Run by Massachusetts General Hospital · NCT05724173 · Data updated 2026-11-12
This study is testing a new brain interface that helps people with tetraplegia, especially those with ALS, control devices like computers just by thinking about it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 3 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 2 sites (Stanford, California and 1 other locations) |
| Status | Recruiting |
| Started | October 18, 2023 |
| Main results expected | July 31, 2027 |
| Study ends | July 31, 2027 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT05724173 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 to 80 with a diagnosis of ALS and severe speech impairment.
✕Probably not a fit
Patients with visual impairments that hinder their ability to use a computer monitor may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the safety and feasibility of the BrainGate2 Neural Interface System, which allows individuals with tetraplegia to control a computer cursor and other assistive devices using their thoughts. Participants will be individuals diagnosed with amyotrophic lateral sclerosis (ALS) who experience severe speech impairment. The study will assess the device's ability to restore certain abilities that are typically reliant on hand movement or speech. The research is conducted at prominent medical institutions to ensure rigorous evaluation and oversight.
Why it matters
Potential benefit: If successful, this technology could significantly enhance the quality of life for patients with severe mobility and communication impairments.
How similar studies have gone: Previous studies using similar neural interface technologies have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Between 18 and 80 years of age. * Participants must have a diagnosis of amyotrophic lateral sclerosis (ALS) as verified by a clinical expert in neurologic diseases. * Participants with a diagnosis of ALS with anarthria, or severe dysarthria with decline in the preceding four months. * Must be within a three-hour drive of the Study site and geographically stable for at least 15 months after enrollment. Exclusion Criteria: * Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses * Chronic oral or intravenous steroids or immunosuppressive therapy * Other serious disease or disorder that could seriously affect ability to participate in the study (There are additional exclusion criteria)
Where it's running
-
Stanford University School of Medicine
Stanford, California, United States Recruiting -
Massachusetts General Hospital
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Jaimie Henderson, MD — Stanford University
- Study coordinator: Leigh R Hochberg, MD, Ph.D
- Email: lhochberg@mgh.harvard.edu
- Phone: 617-724-9247
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using a brain-computer interface to help people with speech difficulties communicate
This study is testing a brain-computer interface to help people who can't speak due to conditions like ALS communicate by turning their thoughts into speech.
-
Feasibility of a brain-computer interface for people with tetraplegia
This study is testing a new brain-computer interface that helps people with tetraplegia control a computer and other devices just by thinking, to see if it’s safe and effective.
-
Investigation of a brain-computer interface system for communication in patients with severe disabilities
This study is testing a new brain-computer interface that helps people with severe disabilities, like tetraplegia and ALS, communicate better by using signals from their brain.
-
Decoding Mandarin speech features from brain-surface signals
This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
Using a brain-computer interface to help people with tetraplegia communicate
This study is testing a new brain-computer interface to help people with tetraplegia communicate more easily using a tablet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.